Data Snapshot - Tafamidis

The HSE Medicines Management Programme provide insights into prescribing trends and utilisation for medicines and non-drug products available through the HSE. This Data Snapshot provides an update on utilisation of tafamidis reimbursed for the treatment of transthyretin amyloidosis with cardiomyopathy subject to a managed access protocol.